IRIS Accounts Production v22.2.0.402 06410206 Board of Directors 1.1.21 31.12.21 31.12.21 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure064102062020-12-31064102062021-12-31064102062021-01-012021-12-31064102062019-12-31064102062020-01-012020-12-31064102062020-12-3106410206ns16:EnglandWales2021-01-012021-12-3106410206ns15:PoundSterling2021-01-012021-12-3106410206ns11:Director12021-01-012021-12-3106410206ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3106410206ns11:SmallEntities2021-01-012021-12-3106410206ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-3106410206ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3106410206ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3106410206ns11:FullAccounts2021-01-012021-12-3106410206ns11:Director22021-01-012021-12-3106410206ns11:CompanySecretary12021-01-012021-12-3106410206ns11:RegisteredOffice2021-01-012021-12-3106410206ns6:CurrentFinancialInstruments2021-12-3106410206ns6:CurrentFinancialInstruments2020-12-3106410206ns6:Non-currentFinancialInstruments2021-12-3106410206ns6:Non-currentFinancialInstruments2020-12-3106410206ns6:ShareCapital2021-12-3106410206ns6:ShareCapital2020-12-3106410206ns6:RetainedEarningsAccumulatedLosses2021-12-3106410206ns6:RetainedEarningsAccumulatedLosses2020-12-3106410206ns6:PlantMachinery2020-12-3106410206ns6:PlantMachinery2021-01-012021-12-3106410206ns6:PlantMachinery2021-12-3106410206ns6:PlantMachinery2020-12-3106410206ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2021-01-012021-12-3106410206ns6:PlantMachineryns6:LeasedAssetsHeldAsLessee2021-12-3106410206ns6:AdditionsToInvestments2021-12-3106410206ns6:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-12-3106410206ns6:CostValuation2021-12-3106410206ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3106410206ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-31
REGISTERED NUMBER: 06410206 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 December 2021

for

Northumbrian Medical Supplies Limited

Northumbrian Medical Supplies Limited (Registered number: 06410206)






Contents of the Financial Statements
for the year ended 31 December 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Northumbrian Medical Supplies Limited

Company Information
for the year ended 31 December 2021







DIRECTORS: Mrs J Tomkins
R Tomkins





SECRETARY: Mrs J Tomkins





REGISTERED OFFICE: Normedica House
4 Ruby Park
Brunswick
Newcastle upon Tyne
Tyne and Wear
NE13 7BA





REGISTERED NUMBER: 06410206 (England and Wales)





ACCOUNTANTS: Clayton & Brewill
Chartered Accountants
Cawley House
149-155 Canal Street
Nottingham
Nottinghamshire
NG1 7HR

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Balance Sheet
31 December 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 107,923 15,601
Investments 5 27,826 -
135,749 15,601

CURRENT ASSETS
Inventories 79,546 118,621
Debtors 6 1,226,215 928,036
Cash at bank and in hand 125,153 250,147
1,430,914 1,296,804
CREDITORS
Amounts falling due within one year 7 434,242 321,348
NET CURRENT ASSETS 996,672 975,456
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,132,421

991,057

CREDITORS
Amounts falling due after more than
one year

8

(114,835

)

(47,501

)

ACCRUALS AND DEFERRED INCOME (1,700 ) (4,700 )
NET ASSETS 1,015,886 938,856

CAPITAL AND RESERVES
Called up share capital 4 4
Retained earnings 1,015,882 938,852
SHAREHOLDERS' FUNDS 1,015,886 938,856

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Balance Sheet - continued
31 December 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 April 2022 and were signed on its behalf by:





R Tomkins - Director


Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements
for the year ended 31 December 2021

1. STATUTORY INFORMATION

Northumbrian Medical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements - continued
for the year ended 31 December 2021

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2020 - 7 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 January 2021 51,556
Additions 99,332
At 31 December 2021 150,888
DEPRECIATION
At 1 January 2021 35,955
Charge for year 7,010
At 31 December 2021 42,965
NET BOOK VALUE
At 31 December 2021 107,923
At 31 December 2020 15,601

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
Additions 97,894
At 31 December 2021 97,894
DEPRECIATION
Charge for year 4,079
At 31 December 2021 4,079
NET BOOK VALUE
At 31 December 2021 93,815

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 40,000
Impairments (12,174 )
At 31 December 2021 27,826
NET BOOK VALUE
At 31 December 2021 27,826

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements - continued
for the year ended 31 December 2021

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 114,909 100,622
Amounts owed by group undertakings 501,279 537,145
Other debtors 610,027 290,269
1,226,215 928,036

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Bank loans and overdrafts 9,998 2,499
Hire purchase contracts 15,800 -
Trade creditors 72,618 114,507
Taxation and social security 205,673 192,082
Other creditors 130,153 12,260
434,242 321,348

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Bank loans 39,076 47,501
Hire purchase contracts 75,759 -
114,835 47,501

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 7,515

9. ULTIMATE CONTROLLING PARTY

The controlling party is TDH Capital Limited.

The ultimate controlling party is TDH Capital Limited.